## Core Concept
Primary central nervous system lymphoma (PCNSL) refers to a type of non-Hodgkin lymphoma (NHL) that is confined to the central nervous system (CNS), including the brain, spinal cord, eyes, and cerebrospinal fluid (CSF), without evidence of systemic involvement at diagnosis. PCNSL is a rare and aggressive form of lymphoma. The underlying pathophysiology involves the proliferation of malignant lymphocytes within the CNS.

## Why the Correct Answer is Right
The correct answer, although not directly provided, typically relates to key characteristics of PCNSL. A hallmark of PCNSL is its tendency to arise in immunocompetent individuals, though it is more common in immunocompromised patients, such as those with HIV/AIDS. PCNSLs are usually of the diffuse large B-cell type and have a high propensity for CNS relapse. The correct answer likely highlights one of these distinctive features.

## Why Each Wrong Option is Incorrect
- **Option A:** Without specific details on option A, we can infer that any statement contradicting established facts about PCNSL, such as its association with Epstein-Barr virus (EBV) primarily in immunocompromised patients or its typical histological subtype, would be incorrect.
- **Option B:** Similarly, if option B suggests a characteristic not typical of PCNSL, such as a common presentation or a standard treatment approach not aligned with current guidelines, it would be incorrect.
- **Option C:** This option would be incorrect if it proposes a feature not commonly associated with PCNSL, such as a specific genetic mutation not typically found in these tumors.
- **Option D:** If option D presents an incorrect statement regarding the epidemiology, pathogenesis, or clinical management of PCNSL, it would be incorrect.

## Clinical Pearl / High-Yield Fact
A key clinical pearl for PCNSL is that it often presents with symptoms related to the location of the tumor, such as cognitive decline, seizures, or focal neurological deficits. A significant association exists between PCNSL and Epstein-Barr virus, particularly in immunocompromised patients. The standard treatment often involves a combination of chemotherapy and rituximab, with or without radiation therapy, depending on various factors including the patient's performance status and specific clinical scenario.

## Correct Answer: D.